Early bird registration is open and closes May 2025. Register now

  • 00Days
  • 00Hrs
  • 00Mins
  • 00Secs
Search

Masayuki Nishide

Affiliation/region: The University of Osaka Hospital, East Asia

Masayuki Nishide graduated from Osaka University School of Medicine in 2007 and completed his initial clinical training at NTT West Japan Osaka Hospital in 2010. After earning his PhD in 2017 from Osaka University, he continued his academic career as an Assistant Professor at Osaka University. From 2020 to 2021, he conducted research as a fellow at Harvard Medical School’s Brigham and Women’s Hospital. In 2025, he was appointed as Director of Clinical Immunology at The University Osaka Hospital. Dr. Nishide is an active member of the Japan College of Rheumatology and a board member of the APLAR young rheumatologists. His expertise lies in investigating the mechanisms of granulocyte activation in immune diseases, with a recent focus on single-cell analyses to identify pathogenic cell subsets in ANCA-associated vasculitis (Nat Commun 2023, manuscripts in revision). His translational research integrates clinical insights and advanced omics, emphasizing patient-centered discoveries (Nat Rev Immunol 2024).

Share

Key dates

Registrations
Abstracts

More speakers

Zhan-guo Li - Peking University People's Hospital

Zhan-guo Li

Peking University People's Hospital, East Asia
Kok-Ooi Kong - Tan Tock Seng Hospital

Kok-Ooi Kong

Tan Tock Seng Hospital, Southeast Asia

Tsutomu Takeuchi (竹内勤)

Keio University, East Asia
Michael Tee - University Of The Philippines Manila

Michael Tee

University Of The Philippines Manila, Southeast Asia
Guochun Wang - China-Japan Friendship Hospital

Guochun Wang

China-Japan Friendship Hospital, East Asia

Mandana Nikpour

The University of Sydney, Australia